Navigation Links
AAAS news briefs from UC Davis
Date:2/21/2011

Researchers from the University of California, Davis, will present these findings at the annual meeting of the American Association for the Advancement of Science in Washington, D.C., on Feb. 17-21.

Presentation: Reducing Greenhouse Gas Emissions from the Transportation Sector
Presenter: Christopher Yang, UC Davis Institute of Transportation Studies
Date and time: Friday, Feb. 18, 2 p.m.
Location: 206 Washington Convention Center
Symposium: Portraits of the California Energy System in 2050: Cutting Emissions by 80 Percent

The transportation sector in California is the largest emitter of greenhouse gases in the state. It is expected to grow significantly over time, due to increasing population and travel demand, especially for air travel and moving goods. Tackling this sector is critical if California is to meet its ambitious greenhouse-gas-reduction targets. This talk will discuss the three main approaches (or "levers") for reducing transportation emissions, including reducing travel demand, improving vehicle efficiency and switching to lower-carbon alternative fuels. Two strategies with high potential are electrification of vehicles to run on hydrogen or electricity, and producing biofuels for use in more conventional combustion engines.

Contact: Christopher Yang, UC Davis Institute of Transportation Studies, ccyang@ucdavis.edu


Presentation: Escalation, Interdependence and Source Populations
Presenter: Geerat Vermeij, UC Davis distinguished professor of geology
Date and time: Saturday, Feb. 19, 9 a.m.
Location: 207A Washington Convention Center
Symposium: Rethinking Adaptation to a Changing Global Environment

Sometimes, predators and prey become involved in an evolutionary "arms race" with each other. Geerat Vermeij, distinguished professor of geology at UC Davis, will discuss the conditions under which this escalation, or "en
'/>"/>

Contact: Sylvia Wright
swright@ucdavis.edu
530-752-7704
University of California - Davis
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Weill Cornell science briefs: November 2009
2. UC Davis chemical ecologist wins major award
3. UC Davis researchers discover a key to aggressive breast cancer
4. UC Davis researchers discover Achilles heel in pancreatic cancer
5. UC Davis researchers exploring gene therapy to fight AIDS
6. UC Davis team refines cancer treatments to reduce potential nerve damage
7. UC Davis discovery offers hope for treating kidney cancer
8. UC Davis researchers find molecule that targets brain tumors
9. UC Davis research shows that newly discovered drug reduces heart enlargement
10. UC Davis bench-to-bedside research: Promising treatment in clinical trials
11. UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... mice exposed to Bisphenol A through their mother,s diet during ... activity and had leaner body mass than those not exposed ... of Public Health have discovered. BPA is a chemical ... cash register receipts. It once was in many hard plastic ...
... from the Jurassic period challenges widely accepted theories on the ... Lecturer in Vertebrate Palaeontology at the University of Southampton, the ... length which pre-dates bird-like dinosaurs that birds were long thought ... it has become accepted among palaeontologists that birds evolved from ...
... of any use, one must first be able to find it. ... too much of it. We are helped by thousands of computers ... digest and comprehend it. In this "ocean" of information, open access ... content that can be harvested, extracted, sorted out and indexed by ...
Cached Biology News:Female mice exposed to BPA by mothers show unexpected characteristics 2Female mice exposed to BPA by mothers show unexpected characteristics 3Pensoft Publishers integrate their journal platform with OpenAIRE 2
(Date:7/28/2015)... -- Faced with increasing challenges such as costly treatments ... the global healthcare industry today is gradually transforming ... or significantly changing the course of a disease, ... medicine as a viable alternative. Regenerative ... with the potential to resolve unmet medical needs ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a professional and ... basic overview of the industry including definitions, classifications, applications and industry chain structure. ... competitive landscape analysis, and key regions development status. Development policies and plans are ...
(Date:7/27/2015)... 27, 2015 Research presented at the 2015 ... on the studies that led to a fingerprick Ebola ... this disease to receive approval from the World Health ... Ebola,s grip on West Africa ... healthcare workers to isolate and treat these patients much ...
(Date:7/27/2015)... NEW YORK , July 27, 2015 ... organizations and startups share information and develop new technology ... The Sachs Policy Group (SPG), a leader in health ... members will now engage in a collaborative innovation process ... through the latest trends in public policy, health care ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today ... of SYMLIN® (pramlintide acetate) injection in patients with type ... completed clinical studies. The data, which will be presented ... of the American Diabetes Association (ADA) in San Diego, ...
... June 24, 2011 /PRNewswire-iReach/ -- Harbour ... today the completion of a non-exclusive research and ... a global pharmaceutical company, to generate and develop ... chains(H2L2) using one of Harbour,s transgenic mouse antibody ...
... 24, 2011 ,   ... 2511) investigated the efficacy and safety of,the monoclonal ... This study showed that in patients with,severe AAV ... and,maintenance over a period of 18 months proved ...
Cached Biology Technology:Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps 2Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps 3Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps 4Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps 5Harbour Antibodies BV Signs Research and Licence Agreement With Lilly 2ERA-EDTA Congress 2011: Late Breaking Clinical Trials I 2
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
... 400 Spun Columns, 10. *SizeSep 400 Spun ... 400 base pairs in length. - ... and pre-equilibrated in distilled water containing 0.15% Kathon ... ~ 400 base pairs. *Extremely useful ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
Detects activated caspases in living cells. Simple/sensitive/straight-forward procedure takes only 30 minutes. Results can be analyzed by flow cytometry/fluorescence microscopy/fluorescence plate rea...
Biology Products: